Relmada Announces FDA Fast Track Designation for d-Methadone for Adjunctive Treatment of Major Depressive Disorder
News
GenPro and Helen F. Graham Cancer Center Present A Novel Epigenetic Biomarker Discovery Approach to a Potential Prognostic Marker for Triple Negative Breast Cancer at NAACR Conference in Washington DC on April 1-4, 2017
Intezyne Technologies Initiates First-In-Human Trials for Topoisomerase-1 Inhibitor IT-141; GRP78 Inhibitor IT-139 to be Featured in AACR SymposiumÂ
QR Pharma, Inc. Presents New Data on Posiphen in Alzheimer’s and Parkinson’s Disease at the 13th AD/PD International Conference
Immigrant-founded Keriton raised $1 million to help keep premature babies on breast milkÂ
Ossianix receives milestone payment from Lundbeck for blood-brain barrier (BBB) antibody delivery technology
Relmada Announces FDA Acceptance of IND and Authorization to Commence Phase 2a Clinical Trial for d-Methadone
Optofluidics announces Hexpoint, a new particle analysis system for early stage formulation
H&T Presspart and Cohero Health Launch First Market-Ready, Fully-Connected Metered Dose Inhaler to Optimize care of Asthma and COPD